000 01194 a2200337 4500
005 20250518081157.0
008 ####s 0 0 eng d
022 _a1948-5875
024 7 _a10.1021/acsmedchemlett.9b00471
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aShouksmith, Andrew E
245 0 0 _aClass I/IIb-Selective HDAC Inhibitor Exhibits Oral Bioavailability and Therapeutic Efficacy in Acute Myeloid Leukemia.
_h[electronic resource]
260 _bACS medicinal chemistry letters
_cJan 2020
300 _a56-64 p.
_bdigital
500 _aPublication Type: Journal Article
700 1 _aGawel, Justyna M
700 1 _aNawar, Nabanita
700 1 _aSina, Diana
700 1 _aRaouf, Yasir S
700 1 _aBukhari, Shazreh
700 1 _aHe, Liying
700 1 _aJohns, Alexandra E
700 1 _aManaswiyoungkul, Pimyupa
700 1 _aOlaoye, Olasunkanmi O
700 1 _aCabral, Aaron D
700 1 _aSedighi, Abootaleb
700 1 _ade Araujo, Elvin D
700 1 _aGunning, Patrick T
773 0 _tACS medicinal chemistry letters
_gvol. 11
_gno. 1
_gp. 56-64
856 4 0 _uhttps://doi.org/10.1021/acsmedchemlett.9b00471
_zAvailable from publisher's website
999 _c30519369
_d30519369